Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoin.
作者信息
Criado P R, Ianhez M, Rocha P S, Miot H A
机构信息
Centro Universitário Faculdade de Medicina do ABC and Alergoskin Alergia e Dermatologia, Santo André, SP, Brazil.
Universidade Federal de Goiás (UFG) and Cório Clínica de Dermatologia, Goiânia, GO, Brazil.
出版信息
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e508-e510. doi: 10.1111/jdv.18055. Epub 2022 Mar 15.
Abstract
摘要
相似文献
1
Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoin.ChAdOx1新冠疫苗接种后发生的I型红皮病性毛发红糠疹：两例口服异维A酸成功治疗的病例报告
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e508-e510. doi: 10.1111/jdv.18055. Epub 2022 Mar 15.
2
Pityriasis rubra pilaris. Further observations of systemic retinoid therapy.红皮病型毛发红糠疹。系统性维甲酸治疗的进一步观察。
J Am Acad Dermatol. 1990 May;22(5 Pt 1):792-5.
3
Efficacy of isotretinoin in pityriasis rubra pilaris: unapproved use.异维A酸治疗毛发红糠疹的疗效：未经批准的用途。
Int J Dermatol. 2006 Oct;45(10):1238-40. doi: 10.1111/j.1365-4632.2006.02932.x.
4
Treatment of classic pityriasis rubra pilaris.经典型毛发红糠疹的治疗。
J Am Acad Dermatol. 1994 Dec;31(6):997-9. doi: 10.1016/s0190-9622(94)70271-3.
5
An old entity, a new trigger: Post COVID-19 vaccine pityriasis rubra pilaris.旧疾宿患，新触发：新冠疫苗后棘层松解性皮病。
Int J Risk Saf Med. 2021;32(4):261-264. doi: 10.3233/JRS-210048.
6
A case of pityriasis rubra pilaris following AstraZeneca COVID-19 vaccine.
JAAD Case Rep. 2022 Jun;24:74-77. doi: 10.1016/j.jdcr.2022.04.020. Epub 2022 May 2.
7
Pityriasis rubra pilaris: a review of diagnosis and treatment.红皮病型毛发红糠疹：诊断与治疗综述
J Am Acad Dermatol. 1989 May;20(5 Pt 1):801-7. doi: 10.1016/s0190-9622(89)70093-1.
8
Isotretinoin treatment of pityriasis rubra pilaris.异维A酸治疗毛发红糠疹。
J Am Acad Dermatol. 1987 Feb;16(2 Pt 1):297-301. doi: 10.1016/s0190-9622(87)70038-3.
9
Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient.一名儿科患者使用依法利珠单抗治疗红皮病型毛发红糠疹取得临床改善。
J Drugs Dermatol. 2007 Mar;6(3):337-9.
10
[Pityriasis rubra pilaris after COVID-19 vaccination: causal relationship or coincidence?].[新冠病毒疫苗接种后红皮病型毛发红糠疹：因果关系还是巧合？]
Dermatologie (Heidelb). 2022 Aug;73(8):634-637. doi: 10.1007/s00105-022-04972-z. Epub 2022 Mar 16.
引用本文的文献
1
Sarcoidosis and Polymethyl Methacrylate (PMMA) Granulomas following COVID-19 Vaccination (ChAdOx1): Successful Treatment with Tofacitinib.新型冠状病毒肺炎疫苗（ChAdOx1）接种后出现的结节病和聚甲基丙烯酸甲酯（PMMA）肉芽肿：托法替布治疗成功
Indian J Dermatol. 2024 Jul-Aug;69(4):328-332. doi: 10.4103/ijd.ijd_56_24. Epub 2024 Aug 19.
2
Pityriasis following COVID-19 vaccinations: a systematic review.新冠病毒疫苗接种后的糠疹：一项系统综述
Dermatol Reports. 2023 Aug 9;16(1):9742. doi: 10.4081/dr.2023.9742. eCollection 2024 Mar 12.
3
Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options.红癣：临床特征、发病机制及治疗选择的最新综述。
Am J Clin Dermatol. 2024 Mar;25(2):243-259. doi: 10.1007/s40257-023-00836-x. Epub 2023 Dec 30.
4
Oral Isotretinoin and Its Uses in Dermatology: A Review.口服异维 A 酸及其在皮肤科的应用：综述。
Drug Des Devel Ther. 2023 Aug 25;17:2573-2591. doi: 10.2147/DDDT.S427530. eCollection 2023.
5
Pityriasis rubra pilaris following COVID-19 vaccination successfully treated with ixekizumab.新冠病毒疫苗接种后发生的红皮病型毛发红糠疹经司库奇尤单抗成功治疗。
JAAD Case Rep. 2023 May;35:52-56. doi: 10.1016/j.jdcr.2023.03.003. Epub 2023 Mar 15.
6
Ixekizumab successfully treated severe pityriasis rubra pilaris after COVID-19 vaccination.司库奇尤单抗成功治疗了新冠疫苗接种后的重度毛发红糠疹。
Skin Health Dis. 2022 Jun 16;3(1):e139. doi: 10.1002/ski2.139.
本文引用的文献
1
Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine.急性发热性嗜中性皮病、毛发红糠疹、急性痘疮样苔藓样糠疹和多形红斑的突然发作：揭示一个可能的共同触发因素——新冠疫苗。
Clin Exp Dermatol. 2022 Feb;47(2):437-440. doi: 10.1111/ced.14970. Epub 2021 Oct 21.
2
An old entity, a new trigger: Post COVID-19 vaccine pityriasis rubra pilaris.旧疾宿患，新触发：新冠疫苗后棘层松解性皮病。
Int J Risk Saf Med. 2021;32(4):261-264. doi: 10.3233/JRS-210048.
3
Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine.接种 BNT163b2（辉瑞-生物科技）mRNA COVID-19 疫苗后出现似红糠疹样疹发。
Clin Exp Dermatol. 2022 Jan;47(1):188-190. doi: 10.1111/ced.14878. Epub 2021 Sep 24.
4
Pityriasis rubra pilaris after Vaxzevria® COVID-19 vaccine.接种Vaxzevria®新冠疫苗后出现毛发红糠疹。
J Eur Acad Dermatol Venereol. 2021 Dec;35(12):e833-e835. doi: 10.1111/jdv.17542. Epub 2021 Aug 12.
5
A Review on Pityriasis Rubra Pilaris.一篇关于红癣的综述。
Am J Clin Dermatol. 2018 Jun;19(3):377-390. doi: 10.1007/s40257-017-0338-1.
6
Pityriasis rubra pilaris occurring after vaccination with diphtheria-pertussis-tetanus and oral poliovirus vaccines.接种白喉-百日咳-破伤风疫苗和口服脊髓灰质炎病毒疫苗后发生的红皮病型毛发红糠疹。
Indian J Dermatol Venereol Leprol. 2015 Nov-Dec;81(6):618-20. doi: 10.4103/0378-6323.168326.
7
Familial pityriasis rubra pilaris is caused by mutations in CARD14.家族性毛发红糠疹是由 CARD14 基因突变引起的。
Am J Hum Genet. 2012 Jul 13;91(1):163-70. doi: 10.1016/j.ajhg.2012.05.010. Epub 2012 Jun 14.
Zotero 插件